A network meta-analysis of 22 randomized controlled trials found that lean mass loss comprises approximately 25% of total weight lost on GLP-1 receptor agonists
10.7150/ijbs.41852 Summary Keywords glutathione S-transferase mu-3, pancreatic cancer, proliferation, ROS, glycolysis Citation Wang S, Yang J, Ding C, Li J, You L, Dai M and Zhao Y (2020) Glutathione S-Transferase Mu-3 Predicts a Better Prognosis and Inhibits Malignant Behavior and Glycolysis in Pancreatic Cancer
Norwitz says.Bottom line: GLP-1 RAs can affect your electrolyte balance through multiple pathways both directly (by changing how your body processes sodium and insulin) and indirectly (by reducing your food and fluid intake or causing GI side effects)
Injections can be administered up to twice a week, and vitamin B-12 is purported by practitioners and users to help accelerate metabolic processes, while creating a greater feeling of overall energy
As a single-center retrospective analysis, it may be subject to selection bias, and conclusions should be validated in large-scale multicenter prospective studies
